Cargando…

Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota

This retrospective cohort study was conducted to determine the prevalence of HCV infections among individuals incarcerated in a state prison system and identify potential contributing factors to HCV infection. North Dakota Department of Corrections and Rehabilitation (NDDOCR) data from 2009 to 2018...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra Deb, Liton, Hove, Hannah, Miller, Tracy K., Pinks, Kodi, Njau, Grace, Hagan, John J., Jansen, Rick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963564/
https://www.ncbi.nlm.nih.gov/pubmed/35349606
http://dx.doi.org/10.1371/journal.pone.0266047
_version_ 1784678015645515776
author Chandra Deb, Liton
Hove, Hannah
Miller, Tracy K.
Pinks, Kodi
Njau, Grace
Hagan, John J.
Jansen, Rick J.
author_facet Chandra Deb, Liton
Hove, Hannah
Miller, Tracy K.
Pinks, Kodi
Njau, Grace
Hagan, John J.
Jansen, Rick J.
author_sort Chandra Deb, Liton
collection PubMed
description This retrospective cohort study was conducted to determine the prevalence of HCV infections among individuals incarcerated in a state prison system and identify potential contributing factors to HCV infection. North Dakota Department of Corrections and Rehabilitation (NDDOCR) data from 2009 to 2018 was used and period prevalence was calculated for this 10-year time period. The period prevalence of HCV infection was (15.13% (95% CI 14.39–15.90) with a marginally significant (p-value: 0.0542) increasing linear trend in annual prevalence over this period. Multivariate logistic regression analysis was used to identify risk factors associated with HCV infection. The main significant independent risk factors for HCV infection in this incarcerated population were age >40 years [OR: 1.78 (1.37–2.32)]; sex [OR: 1.21 (1.03–1.43)]; race/ethnicity [OR: 1.97 (1.69–2.29)]; history of intravenous drug use (IVDU) [OR: 7.36 (6.41–8.44)]; history of needle or syringe sharing [OR: 7.57 (6.62–8.67)]; and alcohol use [OR: 0.87 (0.77–0.99)]. Study limitations include uncollected information on sexual history, frequency or duration of injection drug use and blood transfusion history of the incarcerated population. Considering the high prevalence of HCV infection and its associated risk factors, it is important to implement prevention programs such as syringe/needle exchanges and counsel with imprisoned IVD users.
format Online
Article
Text
id pubmed-8963564
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-89635642022-03-30 Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota Chandra Deb, Liton Hove, Hannah Miller, Tracy K. Pinks, Kodi Njau, Grace Hagan, John J. Jansen, Rick J. PLoS One Research Article This retrospective cohort study was conducted to determine the prevalence of HCV infections among individuals incarcerated in a state prison system and identify potential contributing factors to HCV infection. North Dakota Department of Corrections and Rehabilitation (NDDOCR) data from 2009 to 2018 was used and period prevalence was calculated for this 10-year time period. The period prevalence of HCV infection was (15.13% (95% CI 14.39–15.90) with a marginally significant (p-value: 0.0542) increasing linear trend in annual prevalence over this period. Multivariate logistic regression analysis was used to identify risk factors associated with HCV infection. The main significant independent risk factors for HCV infection in this incarcerated population were age >40 years [OR: 1.78 (1.37–2.32)]; sex [OR: 1.21 (1.03–1.43)]; race/ethnicity [OR: 1.97 (1.69–2.29)]; history of intravenous drug use (IVDU) [OR: 7.36 (6.41–8.44)]; history of needle or syringe sharing [OR: 7.57 (6.62–8.67)]; and alcohol use [OR: 0.87 (0.77–0.99)]. Study limitations include uncollected information on sexual history, frequency or duration of injection drug use and blood transfusion history of the incarcerated population. Considering the high prevalence of HCV infection and its associated risk factors, it is important to implement prevention programs such as syringe/needle exchanges and counsel with imprisoned IVD users. Public Library of Science 2022-03-29 /pmc/articles/PMC8963564/ /pubmed/35349606 http://dx.doi.org/10.1371/journal.pone.0266047 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Chandra Deb, Liton
Hove, Hannah
Miller, Tracy K.
Pinks, Kodi
Njau, Grace
Hagan, John J.
Jansen, Rick J.
Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota
title Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota
title_full Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota
title_fullStr Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota
title_full_unstemmed Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota
title_short Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota
title_sort epidemiology of hepatitis c virus infection among incarcerated populations in north dakota
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963564/
https://www.ncbi.nlm.nih.gov/pubmed/35349606
http://dx.doi.org/10.1371/journal.pone.0266047
work_keys_str_mv AT chandradebliton epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota
AT hovehannah epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota
AT millertracyk epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota
AT pinkskodi epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota
AT njaugrace epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota
AT haganjohnj epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota
AT jansenrickj epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota